ClinicalTrials.gg
Active, not recruitingNCT05974553Updated Oct 26, 2026

Dialectical Behavior Therapy for Justice-Involved Veterans

An interventional study of Dialectical Behavior Therapy for Justice-Involved Veterans and Supportive Group Psychotherapy for Justice-Involved Veterans in Criminal Behavior, Criminal Recidivism and Psychosocial Functioning, sponsored by VA Office of Research and Development. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Primary conditionRecidivismRegistry: Criminal BehaviorReclassifiedWhy we changed it
Registry
Criminal Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Recidivism
Why
  1. Criminal Behavior is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Recidivism, a narrower term within Criminal Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

Updated Oct 26, 2026Now Active, not recruitingEnrollment updated+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
215
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Recidivism with a site in United States — 3 open to participants now, 7 under way, 1 of them phase 3. Recidivism · United States.

Enrollment
15th of 25
215 · median 256
Started
2024
the only one that year
No phase
20 of 26
3 open now
Registered
23rd of 26
by date

Among the 26 studies in Recidivism with a site in United States, this one is the 15th largest by enrollment of the 25 interventional ones that give a count, is the only one that started in 2024, is one of 20 with no phase, and was the 23rd registered.

Recidivism

32 studies on the registry are indexed under Recidivism; 7 are open to participants now.

Browse Recidivism studies →

Open to participants now

3 of the 26 studies in Recidivism with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 4 Recidivism studies recruiting now, 3 set no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Recidivism with a site in United States, or all of them as a file.
02

Study summary

Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive, integrative program distinctively designed to address the range of mental health, substance use, case management, and legal needs of Veterans with current or ongoing criminal justice involvement. Data from two prior clinical trials attest to the program's feasibility and acceptability and preliminarily suggest participation in the program may yield meaningful improvements in risk for criminal behavior and resolution of high-priority case management needs. However, continued research is needed to further investigate the program's efficacy. This Phase III clinical trial aims to investigate the superiority of DBT-J over a supportive group therapy treatment in decreasing risk of future criminal behavior and increasing psychosocial functioning. Secondary and exploratory aims will also investigate superiority of DBT-J in improving secondary treatment targets, potential differential efficacy across special-interest Veteran subgroups, and long-term consequences of program participation.

Read the detailed description

Despite substantial efforts to curb Veteran suicide, Veterans continue to die by suicide at rates that far exceed their civilian peers. To date, substantial resources have been invested into understanding and treating underlying risk factors and precipitants of Veteran suicide. However, criminal justice involvement remains an under-examined and under-assessed risk factor for Veteran suicide. Accumulating research suggests justice-involved Veterans are a high-risk, high need population, particularly within the Veterans Health Administration. For example, 11% of Veteran suicides are precipitated by legal troubles; 79% of Veterans receiving VA supportive housing assistance have a history of one or more arrests; and 58% of Veterans receiving outpatient VHA substance use treatment have a history of three or more arrests. Risk for suicide among justice-involved Veterans is particularly elevated among those with co-occurring difficulties, such as mental health concerns and/or housing instability. Adequately addressing Veteran suicide - both for justice-involved Veterans and the broader Veteran population - therefore likely requires interventions to address the legal and co-occurring difficulties of at-risk Veterans.

Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is distinctively designed to address these range of needs faced by justice-involved Veterans, including heightened suicide risk, antisocial behaviors, mental health and substance use concerns, community-based structural barriers, and case management difficulties. Combining elements of three prominent, evidence-based models, DBT-J provides 16 weeks of group psychotherapy, case management services, and measurement-based care to Veterans with ongoing or recent criminal justice involvement. Data from two prior clinical trials attest to the feasibility and acceptability of DBT-J within VHA behavioral health settings. Although preliminary, data also suggest participation in DBT-J may yield meaningful reductions in risk for future criminal behavior and resolution of high-priority case management needs. Continued research, however, is needed to further investigate the program's efficacy.

Toward these aims, this Phase III clinical trial will:

  1. Primary Aims 1-2: Assess the superiority of DBT-J over supportive group therapy in decreasing risk of future criminal behavior and increasing psychosocial functioning.
  2. Secondary Aim: Assess the superiority of DBT-J over supportive group therapy in improving secondary treatment targets (i.e., suicidal ideation, criminogenic thinking, psychological distress, substance use, case management needs, quality of life, resilience, suicide-related behavior, and criminal recidivism).
  3. Exploratory Aims 1-2: Assess for differential efficacy of DBT-J across high-priority JIV subgroups (i.e., violent versus nonviolent most recent offense type, presence/absence of a substance use disorder, and presence/absence of a severe mental illness); assess long-term impact of DBT-J participation (versus participation in supportive group therapy) on primary and secondary treatment targets.

Up to 250 Veterans with current or recent involvement in the criminal justice system will be recruited from the greater New York City, New York and Denver, Colorado areas to participate in this clinical trial. Veterans will be randomly assigned to receive either 16 weeks of DBT-J or 16 weeks of supportive group therapy followed by a 36 week observational period. Comprehensive assessments of Veteran risk for future criminal justice involvement, psychosocial functioning, suicidal ideation, criminogenic thinking, psychological distress, substance use, case management needs, quality of life, resilience, suicide-related behavior, and criminal recidivism will be administered periodically throughout study completion. Analyses of variance will then be used to compare study conditions on primary and secondary treatment targets and to compare high-priority participant subgroups on primary and secondary treatment targets.

03

Conditions studied

  • Criminal Behavior
  • Criminal Recidivism
  • Psychosocial Functioning

Browse trials for

Keywords

  • Criminal Behavior
  • Criminal Recidivism
  • Psychosocial Functioning
  • Psychotherapy
  • Psychotherapy, Group
  • Case Management
  • Psychiatric Rehabilitation
04

In context

Recidivism Reclassified

32 studies on the registry are indexed under Recidivism; 7 are open to participants now.

This study's enrollment of 215 is below the median of 248 across 30 interventional studies indexed under Recidivism.

Browse Recidivism studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Compared within Recidivism, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Criminal Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran
  • Able to provide consent
  • Current or recent history of criminal justice involvement, defined as

    • (a) criminal arrest, order of protection, or incarceration within two years prior to participation and/or
    • (b) supervision by probation or parole at the time of participation

Exclusion criteria

Exclusion Criteria:

  • Limited English proficiency
  • Inability to tolerate group therapy format
  • Enrollment in a concurrent clinical trial
  • Current or scheduled enrollment in a DBT- or RNR-based program
  • Prior participation in Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) program
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
215 participants (actual)

Study arms

  • Experimental
    Dialectical Behavior Therapy for Justice-Involved Veterans

    16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans

    Behavioral: Dialectical Behavior Therapy for Justice-Involved Veterans

  • Active comparator
    Supportive Group Psychotherapy

    16 weeks of supportive group psychotherapy for justice-involved Veterans

    Behavioral: Supportive Group Psychotherapy for Justice-Involved Veterans

Interventions

  • BehavioralDialectical Behavior Therapy for Justice-Involved Veterans

    16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans, including weekly 60-minute group therapy and biweekly 30-minute individual case management

  • BehavioralSupportive Group Psychotherapy for Justice-Involved Veterans

    16 weeks of clinician-facilitated supportive group psychotherapy for justice-involved Veterans, including weekly 75-minute group psychotherapy (20 hours total intervention). All interventions delivered via telehealth.

07

What researchers measure

Primary outcomes

  1. Level of Service / Case Management Inventory

    semi-structured interview assessment of risk for future criminal justice involvement; score range = 0-43, with higher scores indicating greater risk for future criminal justice involvement

    Time frame: Six times over course of 52 weeks

  2. Inventory of Psychosocial Functioning

    self-report instrument measuring functional impairments in romantic relationships, family relationships, work, friendships and socializing, parenting, education, and self-care; score range = 0-100, with higher scores indicating greater impairment in psychosocial functioning

    Time frame: Six times over course of 52 weeks

Secondary outcomes

  1. Beck Scale for Suicidal Ideation

    self-report instrument measuring nature, frequency, and intensity of suicidal ideation; score range = 0-38, with higher scores indicating greater severity of suicidal ideation

    Time frame: Six times over course of 52 weeks

  2. The Measure of Criminogenic Thinking Styles

    self-report instrument measuring tendency to adopt thinking styles commonly associated with engagement in criminal behavior; score range = 65-325, with higher scores indicating greater tendency to engage in criminogenic thinking styles

    Time frame: Three times over course of 52 weeks

  3. Patient Health Questionnaire-9

    self-report instrument measuring psychological distress; score range = 0-27, with higher scores indicating greater psychological distress

    Time frame: Six times over course of 52 weeks

  4. Alcohol Use Disorders Identification Test

    self-report instrument measuring frequency and volume of alcohol use; score range = 0-40, with higher scores indicating more severe alcohol use

    Time frame: Six times over course of 52 weeks

  5. Drug Abuse Screening Test

    self-report instrument measuring frequency and volume of non-alcohol related substance use; score range = 0-10, with higher scores indicating more severe drug use

    Time frame: Six times over course of 52 weeks

  6. DBT-J Case Management Checklist

    self-report instrument measuring nature and severity of common case management difficulties; score range = 0-3, with higher scores indicating broader, more severe difficulties

    Time frame: Six times over course of 52 weeks

  7. Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form

    self-report instrument measuring quality of life and perceived satisfaction with life circumstances; score range = 16-80, with higher scores indicating greater perceived satisfaction with life circumstances

    Time frame: Six times over course of 52 weeks

  8. Connor-Davidson Resilience Scale

    self-report instrument measuring mental and emotional resilience; score range = 0-4, with higher scores indicating greater resilience

    Time frame: Six times over course of 52 weeks

  9. Suicide attempt

    self-reported or medical chart-documented suicide attempt

    Time frame: 52 weeks

  10. Criminal recidivism

    new official record-documented arrest, violation, or order of protection filed

    Time frame: 52 weeks

  11. Screen for Nonsuicidal Self Injury

    self-report instrument measuring nature and frequency of nonsuicidal self-injury; score range = 0-50, with higher scores indicating greater variation in and frequency of nonsuicidal self-injury

    Time frame: Three times over course of 52 weeks

  12. Difficulties in Emotion Regulation Scale-18

    self-report instrument measuring difficulties in emotion regulation; score range = 18-90, with higher scores indicating greater difficulties in emotion regulation

    Time frame: Six times over course of 52 weeks

  13. Triarchic Psychopathy Measure

    self-report instrument measuring personality traits commonly associated with psychopathy; score range = 0-3, with higher scores indicating more severe psychopathic personality traits

    Time frame: Three times over course of 52 weeks

08

Study locations

2 sites
09

References and documents

Publications

  • Edwards ER, Holliday R, Alter S, Blonigen D, Decker SE, Dichiara A, Epshteyn G, Forster J, Fortuna AJ, Galietta M, Kimbrel NA, Stimmel M, Thomas S, Tsai J, Goodman M. Dialectical behavior therapy for justice-involved veterans: randomized clinical trial protocol comparing treatment approaches for veterans with criminal-legal involvement. BMC Psychol. 2026 Jun 24. doi: 10.1186/s40359-026-04749-2. Online ahead of print. PubMed 42343438 ↗

Individual participant data

Plan to share: No — To preserve participant confidentiality, individual participant data will not be shared with anyone outside of the immediate research team.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jun 2027, 41 months after the start.

Of 20 interventional studies with no phase under Recidivism, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 65. This study's planned 41 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2023
First posted
Aug 3, 2023
StartActual
Jan 1, 2024
Primary completionEst.
Jun 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 26, 2026
Enrollment
200 (estimated)→215 (actual)
Oct 26, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • ChangedBefore Veteran aged 18+Now Veteran
Exclusion criteria
  • EditedPrior participation in Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) program
Oct 26, 2026
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedsuicideSuicide attemptTime frame: 52 weeks
  • EditedcriminalCriminal recidivismTime frame: 52 weeks
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Recruiting→Active, not recruiting
    Enrollment 200 (estimated)→215 (actual)
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • ChangedBefore Veteran aged 18+Now Veteran
    Exclusion criteria
    • EditedPrior participation in Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) program
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedsuicideSuicide attemptTime frame: 52 weeks
    • EditedcriminalCriminal recidivismTime frame: 52 weeks
    + 4 other changes: verification date, description, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05974553
Responsible party
Sponsor
First posted
Aug 3, 2023
Start date
Jan 1, 2024
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

Emily R Edwards, PhD
principal investigator · James J. Peters Veterans Affairs Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion